Terra Nova Asset Management’s Gilead Sciences GILD Stock Holding History

Terra Nova Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,762	Closed	-$219K	–	83
2016 Q3	$219K	Sell	2,762 -4,541	-62%	-$369K	0.48%	55
2016 Q2	$609K	Sell	7,303 -9,331	-56%	-$828K	1.04%	42
2016 Q1	$1.53M	Sell	16,634 -1,130	-6%	-$102K	1.79%	12
2015 Q4	$1.8M	Sell	17,764 -6,606	-27%	-$687K	2%	10
2015 Q3	$2.39M	Buy	24,370 +1,365	+6%	+$152K	2.12%	18
2015 Q2	$2.69M	Buy	23,005 +2,546	+12%	+$278K	2.21%	13
2015 Q1	$2.01M	Buy	+20,459	New	+$2.08M	1.66%	23

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Terra Nova Asset Management's GILD Position: Q4 2016 in Review

Terra Nova Asset Management sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 2,762 shares — an estimated $219K sold.

Terra Nova Asset Management first reported a position in GILD in Q1 2015 and held it in 7 quarters. The position peaked at $2.69M in Q2 2015. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

Terra Nova Asset Management reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
Terra Nova Asset Management sold 2,762 Gilead Sciences shares in Q4 2016, an estimated $219K.
Terra Nova Asset Management first reported a position in Gilead Sciences in Q1 2015 and held it in 7 quarters.
Terra Nova Asset Management's Gilead Sciences position peaked at $2.69M in Q2 2015.
1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Terra Nova Asset Management's 13F filing for Q4 2016, filed 13 Jan 2017.